Skip to main content
. 2021 Jan 21;9(2):76. doi: 10.3390/vaccines9020076

Figure 2.

Figure 2

Estimation of HEK293 cell viability treated with mRNA-RBD-PGS (A) and mRNA-RBD-Lipofectamine 3000 (B) by MTT assay. The results are expressed as means ± SD of triplicate experiments.